FIFARMA Regional Observatory
DATA AT THE SERVICE OF EVERYONE
Conozca el Health Innovation Outlook
El Health Innovation Outlook es uno de los estudios más completos que se ha realizado en América Latina, en el que se analizan e integran 55 indicadores, para comparar el desempeño de 11 países de la región en dos dimensiones: salud e innovación. En este estudio se destacan los avances de Argentina, Brasil, Chile, Colombia, Costa Rica, Ecuador, México, Panamá, Perú, República Dominicana y Uruguay y se identifican los retos y oportunidades para fortalecer sus sistemas de salud.
FIFARMA's Regional Observatory is a new data and analysis space for the sector's ecosystem to have the best information for decision making.
FIFARMA makes available to all interested parties this platform that streamlines access to open data from reliable sources, to provide a complete picture of health in the region in one place.
This is a space in constant evolution, at the service of national authorities, companies, unions, academics, and researchers.
EXPLORE THE DASHBOARDS
Health and Innovation Panorama
These data dashboards provide an agile visualization of the main health indicators in three dimensions: country profiles, health indicators and health innovation. This project is a FIFARMA and Innos collaboration for the promotion of transparency and evidence-based decision making.
Country Profile
Health
Innovation
<span data-metadata=""><span data-buffer="">ANALYSIS
<span data-metadata=""><span data-buffer="">Analysis and comments on the prospects and major challenges in health care
Latin American patients must wait an average of 4.7 years to access innovative or cutting-edge treatments
<span data-metadata=""><span data-buffer="">Observatory
of Health Regulatory Policy for Latin America
OPRES monitors and analyzes health policies and regulations in order to disseminate, explain and contribute to their improvement. A deliberation scenario in partnership with Innos.
Latest publications
Understanding the dynamics of the health sector requires analysis, science and in-depth discussions. Learn about the latest reports published by FIFARMA and our strategic allies.
FIFARMA Patient W.A.I.T. Indicator 2024 — América Latina (ESP)
Mejorar la disponibilidad de medicamentos innovadores en América Latina es una prioridad para todos los actores del sistema de salud, especialmente los formuladores de políticas, los fabricantes farmacéuticos y los pacientes. Desde 2004, la asociación de la industria farmacéutica
europea (EFPIA) aplica el indicador W.A.I.T. para Pacientes (por sus siglas en inglés, Waiting to Access Innovative Therapies – En espera de recibir terapias innovadoras), que permite a las partes interesadas medir la tasa de disponibilidad de medicamentos innovadores en 37 países europeos. Este estudio ha sido replicado para comprender la tasa de disponibilidad en ocho países de América Latina.
FIFARMA Patient W.A.I.T. Indicator 2024 — Latin America
Improving the availability of innovative medicines in Latin America is a priority for all stakeholders in the healthcare system, especially policymakers, pharmaceutical manufacturers, and patients. Since 2004, the European pharmaceutical industry association (E.F.P.I.A.) has run the Patients W.A.I.T. (Waiting to Access Innovative Therapies) Indicator, enabling stakeholders to measure the availability rate of innovative medicines in 37 European countries. This study has been replicated to understand availability rate in eight Latin American Countries.
Financiamiento de la Salud Pública en América Latina: Estudios sobre Argentina, Brasil, Chile, Colombia, México y Perú
El conjunto de artículos que componen esta publicación es resultado de la ejecución de un proyecto realizado en el Instituto de Relaciones Internacionales de la Universidad de São Paulo en 2023 y 2024, con el objetivo de investigar los aspectos económicos de la prestación de servicios de salud en los países de América Latina, concretamente con un análisis cuantita- tivo y cualitativo sobre la inversión en salud en seis países de la región: Argentina, Brasil, Chile, Colombia, México y Perú.
Financiamiento de la Salud Pública en América Latina
Una de nuestras prioridades en la Federación Latinoamericana de la Industria Farmacéutica (FIFARMA) es producir y analizar datos útiles para mejorar los sistemas de salud, esto incluye mostrar a los gobiernos y actores de la salud en la región, que la financiación de la salud es una inversión y no un gasto.
Appraisal of public assessment reports (PARs) as tools to guide reliance decision making by regulatory agencies
Regulatory reliance facilitates regulatory approvals, allows the use of resources more efficiently, and ultimately serves patients by accelerating access to quality-assured, safe, and effective medicines.
Carga socioeconômica das principais doenças em oito países da América Latina
O estudo sobre a Carga Socioeconômica das Doenças na América Latina, desenvolvido pelo Instituto WifOR da Alemanha, utilizou uma metodologia que demonstra que investir na saúde e na geração de países mais saudáveis também cria economias mais saudáveis.
Carga socioeconómica de las principales enfermedades en ocho países de América Latina
El estudio sobre la Carga Socioeconómica de las Enfermedades en América Latina, desarrollado por el Instituto WifOR de Alemania, ha utilizado una metodología que demuestra que invertir en salud y en la generación de países más sanos también crea economías más sanas.
Socioeconomic burden of diseases in Latin America
The study on the Socioeconomic Burden of Diseases in Latin America, developed by the WifOR Institute of Germany, has used a methodology that demonstrates that investing in health and in the generation of healthier countries also creates healthier economies.
Innovative Approaches to Regulatory Reliance
Global Trends and Perspectives for Latin America and the Caribbean
Innovators Book - LATAM Health Champions 2024 - PT
A inovação desempenha um papel crítico no avanço da saúde e seus sistemas
correlatos em todo o mundo. Esses avanços permitem que a humanidade enfrente, com
sucesso crescente, desafios globais como a pandemia da COVID-19, desafios regionais
e locais típicos da evolução dos problemas de saúde…
Innovators Book - LATAM Health Champions 2024 - EN
Innovation plays a critical role in advancing health and healthcare systems globally. These
advancements allow humanity to increasingly successfully face global challenges such
as the COVID-19 pandemic, regional and local challenges inherent in the evolution of
health problems…
Innovators Book - LATAM Health Champions 2024 - ES
La innovación juega un papel crítico en el avance de la salud y los sistemas de salud en el
mundo. Estos avances permiten que la humanidad enfrente, cada vez con más éxito, desafíos
globales como la pandemia del COVID-19, desafíos regionales y locales propios de la
evolución de las problemáticas de salud…
Innovative Approaches to Regulatory Reliance
Global Trends and Perspectives for Latin America and the Caribbean
Latam Health Champions Compendium 2024
Innovation plays a critical role in improving public health and in overcoming global health challenges, and robust intellectual property (IP) rights are key in enabling innovation around the world by providing incentives for innovators to invest research and development (R&D) that produce health innovations.
Explore the databases
Consult the data sources that FIFARMA and its partners make available to researchers, decision makers and authorities in the region.
Contact for researchers
If you have any questions, comments, or requests for information, please contact our team:
Email: info@fifarma.org
